Barclays’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$607K Buy
490,092
+105,065
+27% +$130K ﹤0.01% 2941
2025
Q1
$454K Sell
385,027
-1,275,032
-77% -$1.5M ﹤0.01% 2900
2024
Q4
$3.04M Buy
1,660,059
+1,064,909
+179% +$1.95M ﹤0.01% 1941
2024
Q3
$1.01M Buy
595,150
+350,196
+143% +$595K ﹤0.01% 2616
2024
Q2
$336K Sell
244,954
-420,123
-63% -$576K ﹤0.01% 2754
2024
Q1
$2.49M Buy
665,077
+199,227
+43% +$747K ﹤0.01% 1798
2023
Q4
$4.57M Buy
465,850
+344,041
+282% +$3.38M ﹤0.01% 1555
2023
Q3
$1.02M Sell
121,809
-189,547
-61% -$1.58M ﹤0.01% 2089
2023
Q2
$4.14M Buy
311,356
+156,177
+101% +$2.08M ﹤0.01% 1325
2023
Q1
$1.8M Buy
155,179
+28,211
+22% +$327K ﹤0.01% 1717
2022
Q4
$1.04M Buy
126,968
+34,676
+38% +$283K ﹤0.01% 2097
2022
Q3
$536K Sell
92,292
-87,032
-49% -$505K ﹤0.01% 2549
2022
Q2
$792K Buy
179,324
+18,510
+12% +$81.8K ﹤0.01% 2249
2022
Q1
$1.46M Sell
160,814
-157,996
-50% -$1.44M ﹤0.01% 2030
2021
Q4
$6.52M Buy
318,810
+206,485
+184% +$4.22M ﹤0.01% 1088
2021
Q3
$2.87M Buy
112,325
+53,157
+90% +$1.36M ﹤0.01% 1615
2021
Q2
$2.07M Sell
59,168
-127,189
-68% -$4.45M ﹤0.01% 1696
2021
Q1
$6.21M Buy
186,357
+127,143
+215% +$4.24M ﹤0.01% 1048
2020
Q4
$1.54M Sell
59,214
-17,591
-23% -$456K ﹤0.01% 1740
2020
Q3
$758K Sell
76,805
-48,125
-39% -$475K ﹤0.01% 2087
2020
Q2
$431K Buy
124,930
+49,496
+66% +$171K ﹤0.01% 2404
2020
Q1
$231K Sell
75,434
-679,483
-90% -$2.08M ﹤0.01% 2470
2019
Q4
$3.88M Buy
754,917
+199,323
+36% +$1.02M ﹤0.01% 1421
2019
Q3
$2.87M Buy
555,594
+267,982
+93% +$1.38M ﹤0.01% 1475
2019
Q2
$1.74M Sell
287,612
-67,821
-19% -$410K ﹤0.01% 1926
2019
Q1
$2.57M Sell
355,433
-243,122
-41% -$1.76M ﹤0.01% 1392
2018
Q4
$4.43M Buy
598,555
+444,528
+289% +$3.29M ﹤0.01% 976
2018
Q3
$834K Buy
154,027
+104,955
+214% +$568K ﹤0.01% 2365
2018
Q2
$173K Buy
49,072
+16,509
+51% +$58.2K ﹤0.01% 2818
2018
Q1
$67K Sell
32,563
-69,675
-68% -$143K ﹤0.01% 3354
2017
Q4
$270K Buy
102,238
+99,837
+4,158% +$264K ﹤0.01% 2479
2017
Q3
$13K Buy
2,401
+1,755
+272% +$9.5K ﹤0.01% 3349
2017
Q2
$2K Sell
646
-3,813
-86% -$11.8K ﹤0.01% 3699
2017
Q1
$23K Sell
4,459
-27,153
-86% -$140K ﹤0.01% 3330
2016
Q4
$120K Sell
31,612
-16,128
-34% -$61.2K ﹤0.01% 2531
2016
Q3
$427K Buy
47,740
+46,624
+4,178% +$417K ﹤0.01% 1800
2016
Q2
$7K Sell
1,116
-82,329
-99% -$516K ﹤0.01% 3065
2016
Q1
$668K Buy
83,445
+37,065
+80% +$297K ﹤0.01% 1582
2015
Q4
$603K Buy
46,380
+24,166
+109% +$314K ﹤0.01% 1599
2015
Q3
$66K Buy
22,214
+20,969
+1,684% +$62.3K ﹤0.01% 2499
2015
Q2
$6K Sell
1,245
-1,337
-52% -$6.44K ﹤0.01% 3529
2015
Q1
$13K Sell
2,582
-5,794
-69% -$29.2K ﹤0.01% 3279
2014
Q4
$59K Sell
8,376
-2,014
-19% -$14.2K ﹤0.01% 2932
2014
Q3
$41K Sell
10,390
-16,634
-62% -$65.6K ﹤0.01% 3098
2014
Q2
$162K Buy
27,024
+4,746
+21% +$28.5K ﹤0.01% 2497
2014
Q1
$112K Sell
22,278
-4,667
-17% -$23.5K ﹤0.01% 2715
2013
Q4
$135K Buy
26,945
+25,300
+1,538% +$127K ﹤0.01% 2865
2013
Q3
$9K Sell
1,645
-33,936
-95% -$186K ﹤0.01% 3678
2013
Q2
$90K Buy
+35,581
New +$90K ﹤0.01% 3077